ArticleJournal of current ophthalmology
Tamoxifen Retinopathy or Macular Telangiectasia Type 2: Multicolor Imaging to Clinch the Diagnosis.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To highlight the role of multicolor imaging to differentiate between the two cases presented, macular telangiectasia type 2 (MT 2) and tamoxifen retinopathy (TR) which have very similar phenotypical properties and can often present a diagnostic dilemma. Methods: Retrospective analysis of 2 cases, MT 2 and TR, presenting to a tertiary eye care center in Eastern India. Results: Both the cases show crystalline deposits and similar optical coherence tomography findings. However, MT 2 shows increased reflectance at the perifoveal region on multicolor imaging, while TR shows the same at the foveal region. Conclusion: Differentiating early TR and MT 2 can be challenging, and multicolor imaging, especially blue reflectance, can be very helpful in solving the dilemma and clinching the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.